Cargando…

Novel glucose-lowering drugs for non-alcoholic fatty liver disease

BACKGROUND: The efficacy of novel glucose-lowering drugs in treating non-alcoholic fatty liver disease (NAFLD) is unknown. AIM: To evaluate the efficacy of glucose-lowering drugs dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and sodium-glucose cotr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Zuo-Di, Cai, Xiao-Ling, Yang, Wen-Jia, Zhao, Ming-Ming, Li, Ran, Li, Yu-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807257/ https://www.ncbi.nlm.nih.gov/pubmed/33520110 http://dx.doi.org/10.4239/wjd.v12.i1.84

Ejemplares similares

Association between non-alcoholic fatty liver disease and risk of incident heart failure: a meta-analysis of observational studies
por: Li, Wensheng, et al.
Publicado: (2022)

Statin liver safety in non‐alcoholic fatty liver disease: A systematic review and metanalysis
por: Pastori, Daniele, et al.
Publicado: (2021)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver and metabolic-associated fatty liver with COVID-19 outcomes: A systematic review and meta-analysis
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023)

Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis
por: Liu, Jiaye, et al.
Publicado: (2022)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease
por: Wruck, Wasco, et al.
Publicado: (2017)

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
por: Huang, Yi-Zhou, et al.
Publicado: (2021)

Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis
por: Decharatanachart, Pakanat, et al.
Publicado: (2021)

Clinical application of angiotensin receptor blockers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis
por: Li, Yating, et al.
Publicado: (2018)

PPAR-alpha/gamma agonists, glucagon-like peptide-1 receptor agonists and metformin for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Zhuo-Ya, et al.
Publicado: (2023)

Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis
por: Gong, Hang, et al.
Publicado: (2021)

Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis
por: Mo, Man-Qiu, et al.
Publicado: (2022)

Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis
por: Malandris, Konstantinos, et al.
Publicado: (2023)

Certain sulfonylurea drugs increase serum free fatty acid in diabetic patients: A systematic review and meta-analysis
por: Yu, Ming, et al.
Publicado: (2022)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Meta-analysis reveals gender difference in the association of liver cancer incidence and excess BMI
por: Yao, Kun-Fang, et al.
Publicado: (2017)

Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data
por: Saberi, Behnam, et al.
Publicado: (2018)

Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis
por: Han, Yue, et al.
Publicado: (2016)

Lower risk of liver cancer in patients with schizophrenia: a systematic review and meta-analysis of cohort studies
por: Xu, Dali, et al.
Publicado: (2017)

Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis
por: Xiong, Jianping, et al.
Publicado: (2017)

Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis
por: Pan, Lu, et al.
Publicado: (2021)

Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis
por: Ren, Bangjiaxin, et al.
Publicado: (2022)

Correlations Between Abnormal Glucose Metabolism and Bone Mineral Density or Bone Metabolism
por: Qu, Yang, et al.
Publicado: (2016)

Different techniques for harvesting grafts for living donor liver transplantation: A systematic review and meta-analysis
por: Li, Hui, et al.
Publicado: (2017)

Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis
por: Lin, Chu, et al.
Publicado: (2023)

Alcohol drinking and gastric cancer risk: a meta-analysis of observational studies
por: Wang, Peng-Liang, et al.
Publicado: (2017)

Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
por: Li, Ming-Xuan, et al.
Publicado: (2023)

Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis
por: Guo, Wei, et al.
Publicado: (2018)

Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis
por: Xu, Jia-Ying, et al.
Publicado: (2016)

Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
por: Patel, Parita, et al.
Publicado: (2020)

Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes
por: Shen, Nicole T, et al.
Publicado: (2019)

Cardiovascular events in hyperuricemia population and a cardiovascular benefit-risk assessment of urate-lowering therapies: a systematic review and meta-analysis
por: Zhao, Li, et al.
Publicado: (2020)

Circulating copeptin level and the clinical prognosis of patients with chronic liver disease
por: Tan, Hao-Qian, et al.
Publicado: (2023)

Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic review and meta-analysis
por: Zhang, Hai-Ming, et al.
Publicado: (2019)

The outcomes of intravascular ultrasound-guided drug-eluting stent implantation among patients with complex coronary lesions: a comprehensive meta-analysis of 15 clinical trials and 8,084 patients
por: Fan, Zhong-Guo, et al.
Publicado: (2017)

Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis
por: de Freitas Júnior, João Remí, et al.
Publicado: (2021)

Metabolic benefits of changing sedentary lifestyles in nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials
por: Ma, Qianqian, et al.
Publicado: (2022)

Unraveling the Interplay between Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome in Adolescents: Pathogenesis, Prevalence, and Management Strategies
por: Półkośnik, Kinga, et al.
Publicado: (2023)

Alcohol consumption and gastric cancer risk: a meta-analysis of prospective cohort studies
por: Han, Xue, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_02mnik701esue4c6oj94eim5sh